An Immune Relevant Signature for Predicting Prognoses and Immunotherapeutic Responses in Patients With Muscle-Invasive Bladder Cancer (MIBC)
Cancer Medicine - United Kingdom
doi 10.1002/cam4.2942
Full Text
Open PDFAbstract
Available in full text
Date
February 25, 2020
Authors
Publisher
Wiley